Whole-genome CRISPR/Cas9 screening was performed in CAR-T cells and co-cultured with Glioblastoma (GBM) stem cells (GSCs) to explore the PD-1 dependence genes such as TLE4 and IKZF2 for cancer treatment. Here, IKZF2 is linked to glioblastoma.